Insulin-like growth factor-1 receptor (IGF-1R) is a potential therapeutic target, because it is overexpressed in many cancers, AD, traumatic brain injury, amyotrophic lateral sclerosis (ALS), Friedreich ataxia and aging. The gene discussed is IGF1R; the disease is Alzheimer disease.